Side Effects and Safety# Epitalon Safety Profile# Preclinical record: No significant adverse effects across decades of animal studies Injection site effects: Mild redness and transient discomfort at injection sites Cancer concern: Telomerase activation theoretically risks promoting pre-cancerous cells, though Epitalon studies showed reduced rather than increased tumor incidence Limitation: Safety data predominantly from a single research group without large-scale, independent safety assessments NAD+ Safety Profile# Human trial data: NMN (250-1200 mg/day) and NR (300-2000 mg/day) have shown favorable safety in multiple human studies lasting weeks to months Common effects: Mild GI symptoms (nausea, bloating) at higher doses
Dialogues Clin Neurosci 8:383395
Cao B, Jin M, Brietzke E, McIntyre RS, Wang D, Rosenblat JD, Ragguett RM, Zhang C, Sun X, Rong C, et al
Phytomedicine 96(12):153845
Are the available product options shown before ordering